US Map / New Mexico
State NM

Clinical Trials in New Mexico

New Mexico is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in New Mexico and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 55 actively recruiting studies with New Mexico sites out of 55 registered in total. The busiest research areas in New Mexico are Obesity, Acute Myeloid Leukemia, Recurrent Endometrial Carcinoma. Leading sponsors running trials in the state include National Cancer Institute (NCI), University of New Mexico, NRG Oncology. By stage, New Mexico trials break down as Phase 1 (5), Phase 2 (16), Phase 3 (27), Phase 4 (1).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
55
Recruiting Now
55
← Back to US Map
Top Conditions in New Mexico
Obesity (3)Acute Myeloid Leukemia (2)Recurrent Endometrial Carcinoma (2)Type 2 Diabetes (2)Lung Non-Small Cell Carcinoma (2)Breast Cancer (2)Recurrent Head and Neck Squamous Cell Carcinoma (1)Recurrent Hypopharyngeal Squamous Cell Carcinoma (1)Recurrent Laryngeal Squamous Cell Carcinoma (1)Recurrent Oral Cavity Squamous Cell Carcinoma (1)Recurrent Oropharyngeal Squamous Cell Carcinoma (1)Hematologic Tests (1)

Frequently Asked Questions — Clinical Trials in New Mexico

How many clinical trials are currently recruiting in New Mexico?
ClinicalMetric currently tracks 55 actively recruiting clinical trials with at least one location in New Mexico. The total number of registered studies—including active but not currently enrolling trials—is 55. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in New Mexico?
New Mexico hosts clinical trials across a broad range of medical conditions, including Obesity, Acute Myeloid Leukemia, Recurrent Endometrial Carcinoma, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout New Mexico serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in New Mexico?
To join a clinical trial in New Mexico, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in New Mexico maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in New Mexico

NCT04671667 Phase 2
Recruiting
Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itse...
Condition
Recurrent Head and Neck Squamous Cell Carcinoma
Enrollment
188 pts
Location
United States
Sponsor
National Cancer Institute (NCI
View Trial →
NCT07287631 N/A
Recruiting
Clinical Evaluation of Precision for the Potassium and Ionized Calcium Tests in ...
Condition
Hematologic Tests
Enrollment
425 pts
Location
United States
Sponsor
Abbott Point of Care
View Trial →
NCT05136196 Phase 2
Recruiting
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Tr...
Condition
Clinical Stage III Cutaneous Melanoma AJCC v8
Enrollment
150 pts
Location
United States
Sponsor
National Cancer Institute (NCI
View Trial →
NCT06279013 N/A
Recruiting
Comparing Telephone Symptom Monitoring Interventions for Managing Symptoms and P...
Condition
Hematopoietic and Lymphatic System Neoplasm
Enrollment
600 pts
Location
United States, Puerto Rico
Sponsor
NRG Oncology
View Trial →
NCT06172296 Phase 3
Recruiting
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Tre...
Condition
Ganglioneuroblastoma, Nodular
Enrollment
478 pts
Location
United States, Australia, Canada
Sponsor
National Cancer Institute (NCI
View Trial →
NCT05268796 Phase 2, Phase 3
Recruiting
Telehealth-Enabled Versus In-Person Parent-Mediated Behavioral Treatment for Cha...
Condition
Autism Spectrum Disorder
Enrollment
90 pts
Location
United States
Sponsor
Stanford University
View Trial →
NCT06548360 Phase 3
Recruiting
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Pa...
Condition
NonSegmental Vitiligo
Enrollment
180 pts
Location
United States, Canada
Sponsor
Incyte Corporation
View Trial →
NCT06672146 Phase 2
Recruiting
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia ...
Condition
Acute Myeloid Leukemia
Enrollment
93 pts
Location
United States, Puerto Rico
Sponsor
National Cancer Institute (NCI
View Trial →
NCT07276542 Phase 2, Phase 3
Recruiting
Clinical Trial Exploring the Outpatient Treatment of Phantom Limb Pain With Keta...
Condition
Phantom Limb Syndrome With Pain
Enrollment
30 pts
Location
United States
Sponsor
The Ketamine Research Foundati
View Trial →
NCT06749457 Phase 1, Phase 2
Recruiting
A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase...
Condition
Staphylococcus Aureus
Enrollment
231 pts
Location
United States
Sponsor
AstraZeneca
View Trial →
NCT04566328 Phase 3
Recruiting
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Mu...
Condition
Plasma Cell Myeloma
Enrollment
1,450 pts
Location
United States, Puerto Rico
Sponsor
ECOG-ACRIN Cancer Research Gro
View Trial →
NCT05147792 N/A
Recruiting
The CONFORM Pivotal Trial
Condition
Atrial Fibrillation
Enrollment
1,600 pts
Location
United States, Czechia, France
Sponsor
Conformal Medical, Inc
View Trial →
NCT06679855 Phase 3
Recruiting
Milrinone for Prevention of Post-ligation Cardiac Syndrome Trial
Condition
Post-ligation Cardiac Syndrome
Enrollment
316 pts
Location
United States
Sponsor
NICHD Neonatal Research Networ
View Trial →
NCT06934642 EARLY_Phase 1
Recruiting
Effect of Tirzepatide on Markers of MASLD in Patients With Obesity
Condition
MASLD
Enrollment
8 pts
Location
United States
Sponsor
University of New Mexico
View Trial →
NCT07198074 Phase 3
Recruiting
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Ca...
Condition
Advanced Endometrial Carcinoma
Enrollment
255 pts
Location
United States
Sponsor
National Cancer Institute (NCI
View Trial →
NCT05564390 Phase 2
Recruiting
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatmen...
Condition
Acute Myeloid Leukemia
Enrollment
2,000 pts
Location
United States, Canada, Puerto Rico
Sponsor
National Cancer Institute (NCI
View Trial →
NCT07357090 N/A
Recruiting
Carbon Dioxide Administration and Brain Waste Clearance
Condition
Traumatic Brain Injury
Enrollment
200 pts
Location
United States
Sponsor
Andrew Mayer
View Trial →
NCT06712654 Phase 2
Recruiting
A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in...
Condition
Hyperphosphatemia
Enrollment
168 pts
Location
United States, China
Sponsor
R1 Therapeutics
View Trial →
NCT03908736 Phase 2
Recruiting
Thinking Zinc: a Study of Zinc Supplements on the Navajo Nation
Condition
DNA Damage
Enrollment
100 pts
Location
United States
Sponsor
University of New Mexico
View Trial →
NCT05774951 Phase 3
Recruiting
A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years ...
Condition
Breast Cancer, Early Breast Cancer
Enrollment
4,300 pts
Location
United States, Argentina, Australia
Sponsor
AstraZeneca
View Trial →
NCT06115265 N/A
Recruiting
Ketogenic Diet and Diabetes Demonstration Project
Condition
Type 2 Diabetes
Enrollment
40 pts
Location
United States
Sponsor
University of New Mexico
View Trial →
NCT01810913 Phase 2, Phase 3
Recruiting
Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizum...
Condition
Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma
Enrollment
613 pts
Location
United States, Canada, Hong Kong
Sponsor
National Cancer Institute (NCI
View Trial →
NCT05950464 Phase 1
Recruiting
Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the...
Condition
Recurrent Endometrial Carcinoma
Enrollment
65 pts
Location
United States
Sponsor
National Cancer Institute (NCI
View Trial →
NCT06952504 Phase 3
Recruiting
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrol...
Condition
Endometrial Cancer
Enrollment
1,123 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
View Trial →
NCT04251052 N/A
Recruiting
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations t...
Condition
Ovarian Carcinoma
Enrollment
1,956 pts
Location
United States, Canada, South Korea
Sponsor
NRG Oncology
View Trial →
Page 1 of 3 — 55 trials total
Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology